{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["6-gingerol", "6-paradol", "SARS-CoV-2 Egyptian strain", "SARS-CoV-2 main protease", "coronavirus", "gardenin A", "thymoquinone"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35893619", "DateRevised": {"Year": "2022", "Month": "07", "Day": "31"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "07", "Day": "24"}], "Language": ["eng"], "ELocationID": ["1914", "10.3390/plants11151914"], "Journal": {"ISSN": "2223-7747", "JournalIssue": {"Volume": "11", "Issue": "15", "PubDate": {"Year": "2022", "Month": "Jul", "Day": "24"}}, "Title": "Plants (Basel, Switzerland)", "ISOAbbreviation": "Plants (Basel)"}, "ArticleTitle": "Bio-Guided Isolation of SARS-CoV-2 Main Protease Inhibitors from Medicinal Plants: In Vitro Assay and Molecular Dynamics.", "Abstract": {"AbstractText": ["Since the emergence of the pandemic of the coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the discovery of antiviral phytoconstituents from medicinal plants against SARS-CoV-2 has been comprehensively researched. In this study, thirty-three plants belonging to seventeen different families used traditionally in Saudi Arabia were tested in vitro for their ability to inhibit the SARS-CoV-2 main protease (M<sup>PRO</sup>). Major constituents of the bio-active extracts were isolated and tested for their inhibition potential against this enzyme; in addition, their antiviral activity against the SARS-CoV-2 Egyptian strain was assessed. Further, the thermodynamic stability of the best active compounds was studied through focused comparative insights for the active metabolites regarding ligand-target binding characteristics at the molecular level. Additionally, the obtained computational findings provided useful directions for future drug optimization and development. The results revealed that <i>Psiadia punctulata</i>, <i>Aframomum melegueta</i>, and <i>Nigella sativa</i> extracts showed a high percentage of inhibition of 66.4, 58.7, and 31.5%, against SARS-CoV-2 M<sup>PRO</sup>, respectively. The major isolated constituents of these plants were identified as gardenins A and B (from <i>P. punctulata</i>), 6-gingerol and 6-paradol (from <i>A. melegueta</i>), and thymoquinone (from <i>N. sativa</i>). These compounds are the first to be tested invitro against SARS-CoV-2 M<sup>PRO</sup>. Among the isolated compounds, only thymoquinone (THY), gardenin A (GDA), 6-gingerol (GNG), and 6-paradol (PAD) inhibited the SARS-CoV-2 M<sup>PRO</sup> enzyme with inhibition percentages of 63.21, 73.80, 65.2, and 71.8%, respectively. In vitro assessment of SARS-CoV-2 (hCoV-19/Egypt/NRC-03/2020 (accession number on GSAID: EPI_ISL_430820) revealed a strong-to-low antiviral activity of the isolated compounds. THY showed relatively high cytotoxicity and was anti-SARS-CoV-2, while PAD demonstrated a cytotoxic effect on the tested VERO cells with a selectivity index of CC<sub>50</sub>/IC<sub>50</sub> = 1.33 and CC<sub>50</sub>/IC<sub>50</sub> = 0.6, respectively. Moreover, GNG had moderate activity at non-cytotoxic concentrations in vitro with a selectivity index of CC<sub>50</sub>/IC<sub>50</sub> = 101.3/43.45 = 2.3. Meanwhile, GDA showed weak activity with a selectivity index of CC<sub>50</sub>/IC<sub>50</sub> = 246.5/83.77 = 2.9. The thermodynamic stability of top-active compounds revealed preferential stability and SARS-CoV-2 M<sup>PRO</sup> binding affinity for PAD through molecular-docking-coupled molecular dynamics simulation. The obtained results suggest the treating potential of these plants and/or their active metabolites for COVID-19. However, further in-vivo and clinical investigations are required to establish the potential preventive and treatment effectiveness of these plants and/or their bio-active compounds in COVID-19."]}, "AuthorList": [{"Identifier": ["0000-0002-0234-7492"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia."}], "LastName": "Abdallah", "ForeName": "Hossam M", "Initials": "HM"}, {"Identifier": ["0000-0002-5864-1674"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt."}], "LastName": "El-Halawany", "ForeName": "Ali M", "Initials": "AM"}, {"Identifier": ["0000-0002-0597-482X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt."}], "LastName": "Darwish", "ForeName": "Khaled M", "Initials": "KM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia."}], "LastName": "Algandaby", "ForeName": "Mardi M", "Initials": "MM"}, {"Identifier": ["0000-0002-2971-6008"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia."}], "LastName": "Mohamed", "ForeName": "Gamal A", "Initials": "GA"}, {"Identifier": ["0000-0002-6858-7560"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Preparatory Year Program, Department of Chemistry, Batterjee Medical College, Jeddah 21442, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Assiut University, Assiut 71526, Egypt."}], "LastName": "Ibrahim", "ForeName": "Sabrin R M", "Initials": "SRM"}, {"Identifier": ["0000-0003-0179-9793"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia."}], "LastName": "Koshak", "ForeName": "Abdulrahman E", "Initials": "AE"}, {"Identifier": ["0000-0003-3799-0581"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia."}], "LastName": "Elhady", "ForeName": "Sameh S", "Initials": "SS"}, {"Identifier": ["0000-0003-4986-1904"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia."}], "LastName": "Fadil", "ForeName": "Sana A", "Initials": "SA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia."}], "LastName": "Alqarni", "ForeName": "Ali A", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, King Abdulaziz University, Jeddah 21589, Saudi Arabia."}], "LastName": "Abdel-Naim", "ForeName": "Ashraf B", "Initials": "AB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia."}], "LastName": "Elfaky", "ForeName": "Mahmoud A", "Initials": "MA"}], "GrantList": [{"GrantID": "RG-4-130-42", "Agency": "Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah,", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Plants (Basel)", "NlmUniqueID": "101596181", "ISSNLinking": "2223-7747"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Zu Z.Y., Jiang M.D., Xu P.P., Chen W., Ni Q.Q., Lu G.M., Zhang L.J. Coronavirus disease 2019 (COVID-19): A perspective from China. Radiology. 2020;296:E15\u2013E25. doi: 10.1148/radiol.2020200490.", "ArticleIdList": ["10.1148/radiol.2020200490", "PMC7233368", "32083985"]}, {"Citation": "Shin D., Mukherjee R., Grewe D., Bojkova D., Baek K., Bhattacharya A., Schulz L., Widera M., Mehdipour A.R., Tascher G. Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity. Nature. 2020;587:657\u2013662. doi: 10.1038/s41586-020-2601-5.", "ArticleIdList": ["10.1038/s41586-020-2601-5", "PMC7116779", "32726803"]}, {"Citation": "Zhang L., Lin D., Sun X., Curth U., Drosten C., Sauerhering L., Becker S., Rox K., Hilgenfeld R. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors. Science. 2020;368:409\u2013412. doi: 10.1126/science.abb3405.", "ArticleIdList": ["10.1126/science.abb3405", "PMC7164518", "32198291"]}, {"Citation": "Ahlquist P. RNA-dependent RNA polymerases, viruses, and RNA silencing. Science. 2002;296:1270\u20131273. doi: 10.1126/science.1069132.", "ArticleIdList": ["10.1126/science.1069132", "12016304"]}, {"Citation": "Kim Y., Jedrzejczak R., Maltseva N.I., Wilamowski M., Endres M., Godzik A., Michalska K., Joachimiak A. Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2. Protein Sci. 2020;29:1596\u20131605. doi: 10.1002/pro.3873.", "ArticleIdList": ["10.1002/pro.3873", "PMC7264519", "32304108"]}, {"Citation": "Li F. Structure, function, and evolution of coronavirus spike proteins. Annu. Rev. Virol. 2016;3:237\u2013261. doi: 10.1146/annurev-virology-110615-042301.", "ArticleIdList": ["10.1146/annurev-virology-110615-042301", "PMC5457962", "27578435"]}, {"Citation": "Shang J., Wan Y., Liu C., Yount B., Gully K., Yang Y., Auerbach A., Peng G., Baric R., Li F. Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry. PLoS Path. 2020;16:e1008392. doi: 10.1371/journal.ppat.1008392.", "ArticleIdList": ["10.1371/journal.ppat.1008392", "PMC7082060", "32150576"]}, {"Citation": "Jo S., Kim S., Shin D.H., Kim M.-S. Inhibition of SARS-CoV 3CL protease by flavonoids. J. Enzym. Inhib. Med. Chem. 2020;35:145\u2013151. doi: 10.1080/14756366.2019.1690480.", "ArticleIdList": ["10.1080/14756366.2019.1690480", "PMC6882434", "31724441"]}, {"Citation": "Khaerunnisa S., Kurniawan H., Awaluddin R., Suhartati S., Soetjipto S. Potential inhibitor of COVID-19 main protease (Mpro) from several medicinal plant compounds by molecular docking study. Preprint. 2020:2020030226. doi: 10.20944/preprints202003.0226.v1.", "ArticleIdList": ["10.20944/preprints202003.0226.v1"]}, {"Citation": "Denaro M., Smeriglio A., Barreca D., De Francesco C., Occhiuto C., Milano G., Trombetta D. Antiviral activity of plants and their isolated bioactive compounds: An update. Phytother. Res. 2020;34:742\u2013768. doi: 10.1002/ptr.6575.", "ArticleIdList": ["10.1002/ptr.6575", "31858645"]}, {"Citation": "Siddiqui A.J., Danciu C., Ashraf S.A., Moin A., Singh R., Alreshidi M., Patel M., Jahan S., Kumar S., Alkhinjar M.I. Plants-derived biomolecules as potent antiviral phytomedicines: New insights on ethnobotanical evidences against coronaviruses. Plants. 2020;9:1244. doi: 10.3390/plants9091244.", "ArticleIdList": ["10.3390/plants9091244", "PMC7570315", "32967179"]}, {"Citation": "Sayed A.M., Khattab A.R., AboulMagd A.M., Hassan H.M., Rateb M.E., Zaid H., Abdelmohsen U.R. Nature as a treasure trove of potential anti-SARS-CoV drug leads: A structural/mechanistic rationale. RSC Adv. 2020;10:19790\u201319802. doi: 10.1039/D0RA04199H.", "ArticleIdList": ["10.1039/D0RA04199H", "PMC9122629", "35685913"]}, {"Citation": "Ali S., Alam M., Khatoon F., Fatima U., Elasbali A.M., Adnan M., Islam A., Hassan M.I., Snoussi M., De Feo V. Natural products can be used in therapeutic management of COVID-19: Probable mechanistic insights. Biomed. Pharmacother. 2022;147:112658. doi: 10.1016/j.biopha.2022.112658.", "ArticleIdList": ["10.1016/j.biopha.2022.112658", "PMC8769927", "35066300"]}, {"Citation": "Ullah S., Munir B., Al-Sehemi A.G., Muhammad S., Haq I.-U., Aziz A., Ahmed B., Ghaffar A. Identification of phytochemical inhibitors of SARS-CoV-2 protease 3CL-Pro from selected medicinal plants as per molecular docking, bond energies and amino acid binding energies. Saudi J. Biol. Sci. 2022;29:103274. doi: 10.1016/j.sjbs.2022.03.024.", "ArticleIdList": ["10.1016/j.sjbs.2022.03.024", "PMC8944115", "35345871"]}, {"Citation": "Shree P., Mishra P., Selvaraj C., Singh S.K., Chaube R., Garg N., Tripathi Y.B. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants\u2013Withania somnifera (Ashwagandha), Tinospora cordifolia (Giloy) and Ocimum sanctum (Tulsi)\u2014A molecular docking study. J. Biomol. Struct. Dyn. 2022;40:190\u2013203. doi: 10.1080/07391102.2020.1810778.", "ArticleIdList": ["10.1080/07391102.2020.1810778", "PMC7484581", "32851919"]}, {"Citation": "Alhadrami H.A., Burgio G., Thissera B., Orfali R., Jiffri S.E., Yaseen M., Sayed A.M., Rateb M.E. Neoechinulin A as a promising SARS-CoV-2 Mpro inhibitor: In vitro and in silico study showing the ability of simulations in discerning active from inactive enzyme inhibitors. Mar. Drugs. 2022;20:163. doi: 10.3390/md20030163.", "ArticleIdList": ["10.3390/md20030163", "PMC8955780", "35323462"]}, {"Citation": "Abdallah H.M., El-Halawany A.M., Sirwi A., El-Araby A.M., Mohamed G.A., Ibrahim S.R., Koshak A.E., Asfour H.Z., Awan Z.A., Elfaky M.A. Repurposing of some natural product isolates as SARS-CoV-2 main protease inhibitors via in vitro cell free and cell-based antiviral assessments and molecular modeling approaches. Pharmaceuticals. 2021;14:213. doi: 10.3390/ph14030213.", "ArticleIdList": ["10.3390/ph14030213", "PMC8001104", "33806331"]}, {"Citation": "Alhadrami H.A., Sayed A.M., Hassan H.M., Youssif K.A., Gaber Y., Moatasim Y., Kutkat O., Mostafa A., Ali M.A., Rateb M.E. Cnicin as an anti-SARS-CoV-2: An integrated in silico and in vitro approach for the rapid identification of potential COVID-19 therapeutics. Antibiotics. 2021;10:542. doi: 10.3390/antibiotics10050542.", "ArticleIdList": ["10.3390/antibiotics10050542", "PMC8150330", "34066998"]}, {"Citation": "Akindele A.J., Sowemimo A., Agunbiade F.O., Sofidiya M.O., Awodele O., Ade-Ademilua O., Orabueze I., Ishola I.O., Ayolabi C.I., Salu O.B. Bioprospecting for Anti-COVID-19 Interventions From African Medicinal Plants: A Review. Nat. Prod. Commun. 2022;17:1934578X221096968. doi: 10.1177/1934578X221096968.", "ArticleIdList": ["10.1177/1934578X221096968"]}, {"Citation": "Abdallah H.M., Zakaria E.M., El-Halawany A.M., Mohamed G.A., Safo M.K., El-Bassossy H.M. Psiadia punctulata major flavonoids alleviate exaggerated vasoconstriction produced by advanced glycation end products. PLoS ONE. 2019;14:e0222101. doi: 10.1371/journal.pone.0222101.", "ArticleIdList": ["10.1371/journal.pone.0222101", "PMC6730914", "31491007"]}, {"Citation": "El Halawany A.M., Sayed N.S.E., Abdallah H.M., El Dine R.S. Protective effects of gingerol on streptozotocin-induced sporadic Alzheimer\u2019s disease: Emphasis on inhibition of \u03b2-amyloid, COX-2, alpha-, beta-secretases and APH1a. Sci. Rep. 2017;7:2902. doi: 10.1038/s41598-017-02961-0.", "ArticleIdList": ["10.1038/s41598-017-02961-0", "PMC5460182", "28588301"]}, {"Citation": "Rafeeq M., Murad H.A.S., Abdallah H.M., El-Halawany A.M. Protective effect of 6-paradol in acetic acid-induced ulcerative colitis in rats. BMC Complement. Med. Ther. 2021;21:28.", "ArticleIdList": ["PMC7805070", "33441125"]}, {"Citation": "Zhu L., George S., Schmidt M.F., Al-Gharabli S.I., Rademann J., Hilgenfeld R. Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease. Antivir. Res. 2011;92:204\u2013212. doi: 10.1016/j.antiviral.2011.08.001.", "ArticleIdList": ["10.1016/j.antiviral.2011.08.001", "PMC7114241", "21854807"]}, {"Citation": "Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods. 1983;65:55\u201363. doi: 10.1016/0022-1759(83)90303-4.", "ArticleIdList": ["10.1016/0022-1759(83)90303-4", "6606682"]}, {"Citation": "Mostafa A., Kandeil A., AMM Elshaier Y., Kutkat O., Moatasim Y., Rashad A.A., Shehata M., Gomaa M.R., Mahrous N., Mahmoud S.H. FDA-approved drugs with potent in vitro antiviral activity against severe acute respiratory syndrome coronavirus 2. Pharmaceuticals. 2020;13:443. doi: 10.3390/ph13120443.", "ArticleIdList": ["10.3390/ph13120443", "PMC7761982", "33291642"]}, {"Citation": "Al-Rabia M.W., Alhakamy N.A., Ahmed O.A.A., Eljaaly K., Alaofi A.L., Mostafa A., Asfour H.Z., Aldarmahi A.A., Darwish K.M., Ibrahim T.S., et al. Repurposing of Sitagliptin- Melittin Optimized Nanoformula against SARS-CoV-2; Antiviral Screening and Molecular Docking Studies. Pharmaceutics. 2021;13:307. doi: 10.3390/pharmaceutics13030307.", "ArticleIdList": ["10.3390/pharmaceutics13030307", "PMC8025909", "33652894"]}, {"Citation": "Mesecar A.D. A Taxonomically-Driven Approach to Development of Potent, Broad-Spectrum Inhibitors of Coronavirus Main Protease Including SARS-CoV-2 (COVID-19) Center for Structural Genomics of Infectious Diseases (CSGID); Chicago, IL, USA: 2020. RcSB Protein Data Bank."}, {"Citation": "Sharun K., Tiwari R., Dhama K. Protease inhibitor GC376 for COVID-19: Lessons learned from feline infectious peritonitis. Ann. Med. Surg. 2021;61:122\u2013125. doi: 10.1016/j.amsu.2020.12.030.", "ArticleIdList": ["10.1016/j.amsu.2020.12.030", "PMC7797473", "33456770"]}, {"Citation": "Douangamath A., Fearon D., Gehrtz P., Krojer T., Lukacik P., Owen C.D., Resnick E., Strain-Damerell C., Aimon A., \u00c1br\u00e1nyi-Balogh P., et al. Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease. Nat. Commun. 2020;11:5047. doi: 10.1038/s41467-020-18709-w.", "ArticleIdList": ["10.1038/s41467-020-18709-w", "PMC7542442", "33028810"]}, {"Citation": "Gimeno A., Mestres-Truyol J., Ojeda-Montes M.J., Macip G., Saldivar-Espinoza B., Cereto-Massagu\u00e9 A., Pujadas G., Garcia-Vallv\u00e9 S. Prediction of Novel Inhibitors of the Main Protease (M-pro) of SARS-CoV-2 through Consensus Docking and Drug Reposition. Int. J. Mol. Sci. 2020;21:3793. doi: 10.3390/ijms21113793.", "ArticleIdList": ["10.3390/ijms21113793", "PMC7312484", "32471205"]}, {"Citation": "El Raey M.A., El-Hagrassi A.M., Osman A.F., Darwish K.M., Emam M. Acalypha wilkesiana flowers: Phenolic profiling, cytotoxic activity of their biosynthesized silver nanoparticles and molecular docking study for its constituents as Topoisomerase-I inhibitors. Biocatal. Agric. Biotechnol. 2019;20:101243. doi: 10.1016/j.bcab.2019.101243.", "ArticleIdList": ["10.1016/j.bcab.2019.101243"]}, {"Citation": "Almalki A.J., Ibrahim T.S., Elhady S.S., Hegazy W.A.H., Darwish K.M. Computational and Biological Evaluation of \u03b2-Adrenoreceptor Blockers as Promising Bacterial Anti-Virulence Agents. Pharmaceuticals. 2022;15:110. doi: 10.3390/ph15020110.", "ArticleIdList": ["10.3390/ph15020110", "PMC8877484", "35215223"]}, {"Citation": "The PyMOL Molecular Graphics System, 2.0.6. Schr\u00f6dinger, LLC; New York, NY, USA: 2021."}, {"Citation": "Ross G.A., Rustenburg A.S., Grinaway P.B., Fass J., Chodera J.D. Biomolecular Simulations under Realistic Macroscopic Salt Conditions. J. Phys. Chem. B. 2018;122:5466\u20135486. doi: 10.1021/acs.jpcb.7b11734.", "ArticleIdList": ["10.1021/acs.jpcb.7b11734", "PMC6078207", "29649876"]}, {"Citation": "Zaki A.A., Ashour A., Elhady S.S., Darwish K.M., Al-Karmalawy A.A. Calendulaglycoside A Showing Potential Activity Against SARS-CoV-2 Main Protease: Molecular Docking, Molecular Dynamics, and SAR Studies. J. Tradit. Complement. Med. 2021;12:16\u201334. doi: 10.1016/j.jtcme.2021.05.001.", "ArticleIdList": ["10.1016/j.jtcme.2021.05.001", "PMC8126476", "34026584"]}, {"Citation": "Saleh A.H., Abdelwaly A., Darwish K.M., Eissa A., Chittiboyina A., Helal M.A. Deciphering the molecular basis of the kappa opioid receptor selectivity: A Molecular Dynamics study. J. Mol. Graph. Modell. 2021;106:107940. doi: 10.1016/j.jmgm.2021.107940.", "ArticleIdList": ["10.1016/j.jmgm.2021.107940", "34015577"]}, {"Citation": "Tuble S.C., Anwar J., Gale J.D. An Approach to Developing a Force Field for Molecular Simulation of Martensitic Phase Transitions between Phases with Subtle Differences in Energy and Structure. J. Am. Chem. Soc. 2004;126:396\u2013405. doi: 10.1021/ja0356131.", "ArticleIdList": ["10.1021/ja0356131", "14709107"]}, {"Citation": "Darden T., York D., Pedersen L. Particle mesh Ewald: An N\u22c5log(N) method for Ewald sums in large systems. J. Chem. Phys. 1993;98:10089\u201310092. doi: 10.1063/1.464397.", "ArticleIdList": ["10.1063/1.464397"]}, {"Citation": "Hess B., Bekker H., Berendsen H.J.C., Fraaije J.G.E.M. LINCS: A linear constraint solver for molecular simulations. J. Comput. Chem. 1997;18:1463\u20131472. doi: 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H.", "ArticleIdList": ["10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H"]}, {"Citation": "P\u00e1ll S., Hess B. A flexible algorithm for calculating pair interactions on SIMD architectures. Comput. Phys. Commun. 2013;184:2641\u20132650. doi: 10.1016/j.cpc.2013.06.003.", "ArticleIdList": ["10.1016/j.cpc.2013.06.003"]}, {"Citation": "Kumari R., Kumar R., Lynn A. g_mmpbsa\u2014A GROMACS Tool for High-Throughput MM-PBSA Calculations. J. Chem. Inf. Model. 2014;54:1951\u20131962. doi: 10.1021/ci500020m.", "ArticleIdList": ["10.1021/ci500020m", "24850022"]}, {"Citation": "Rizvi S.M.D., Hussain T., Moin A., Dixit S.R., Mandal S.P., Adnan M., Jamal Q.M.S., Sharma D.C., Alanazi A.S., Unissa R. Identifying the most potent dual-targeting compound (s) against 3CLprotease and NSP15exonuclease of SARS-CoV-2 from Nigella sativa: Virtual screening via physicochemical properties, docking and dynamic simulation analysis. Processes. 2021;9:1814. doi: 10.3390/pr9101814.", "ArticleIdList": ["10.3390/pr9101814"]}, {"Citation": "Esharkawy E.R., Almalki F., Hadda T.B. In vitro Potential Antiviral SARS-CoV-19-Activity of Natural Product Thymohydroquinone and Dithymoquinone from Nigela sativia. Bioorg. Chem. 2022;120:105587. doi: 10.1016/j.bioorg.2021.105587.", "ArticleIdList": ["10.1016/j.bioorg.2021.105587", "PMC8719923", "35026560"]}, {"Citation": "Khazdair M.R., Ghafari S., Sadeghi M. Possible therapeutic effects of Nigella sativa and its thymoquinone on COVID-19. Pharm. Biol. 2021;59:696\u2013703. doi: 10.1080/13880209.2021.1931353.", "ArticleIdList": ["10.1080/13880209.2021.1931353", "PMC8204995", "34110959"]}, {"Citation": "Kadil Y., Mouhcine M., Filali H. In silico investigation of the SARS CoV2 protease with thymoquinone, the Major Constituent of Nigella Sativa. Curr. Drug Disc. Technol. 2021;18:570\u2013573. doi: 10.2174/1570163817666200712164406.", "ArticleIdList": ["10.2174/1570163817666200712164406", "32652915"]}, {"Citation": "Xu H., Liu B., Xiao Z., Zhou M., Ge L., Jia F., Liu Y., Jin H., Zhu X., Gao J. Computational and experimental studies reveal that thymoquinone blocks the entry of coronaviruses into in vitro cells. Infect. Dis. Ther. 2021;10:483\u2013494. doi: 10.1007/s40121-021-00400-2.", "ArticleIdList": ["10.1007/s40121-021-00400-2", "PMC7853165", "33532909"]}, {"Citation": "Al Amri A.M., Bamosa A.O. Phase I safety and clinical activity study of thymoquinone in patients with advanced refractory malignant disease. Shiraz E. Med. J. 2009;10:107\u2013111."}, {"Citation": "Alkharfy K.M., Ahmad A., Khan R., Al-Shagha W.M. Pharmacokinetic plasma behaviors of intravenous and oral bioavailability of thymoquinone in a rabbit model. Eur. J. Drug Metab. Pharmacokinet. 2015;40:319\u2013323. doi: 10.1007/s13318-014-0207-8.", "ArticleIdList": ["10.1007/s13318-014-0207-8", "24924310"]}, {"Citation": "Oso B.J., Adeoye A.O., Olaoye I.F. Pharmacoinformatics and hypothetical studies on allicin, curcumin, and gingerol as potential candidates against COVID-19-associated proteases. J. Biomol. Struct. Dyn. 2022;40:389\u2013400. doi: 10.1080/07391102.2020.1813630.", "ArticleIdList": ["10.1080/07391102.2020.1813630", "32876538"]}, {"Citation": "Kanjanasirirat P., Suksatu A., Manopwisedjaroen S., Munyoo B., Tuchinda P., Jearawuttanakul K., Seemakhan S., Charoensutthivarakul S., Wongtrakoongate P., Rangkasenee N. High-content screening of Thai medicinal plants reveals Boesenbergia rotunda extract and its component Panduratin A as anti-SARS-CoV-2 agents. Sci. Rep. 2020;10:19963. doi: 10.1038/s41598-020-77003-3.", "ArticleIdList": ["10.1038/s41598-020-77003-3", "PMC7672115", "33203926"]}, {"Citation": "Zick S.M., Djuric Z., Ruffin M.T., Litzinger A.J., Normolle D.P., Alrawi S., Feng M.R., Brenner D.E. Pharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol and conjugate metabolites in healthy human subjects. Cancer Epidemiol. Prev. Biomark. 2008;17:1930\u20131936. doi: 10.1158/1055-9965.EPI-07-2934.", "ArticleIdList": ["10.1158/1055-9965.EPI-07-2934", "PMC2676573", "18708382"]}, {"Citation": "Kim Y., Lovell S., Tiew K.C., Mandadapu S.R., Alliston K.R., Battaile K.P., Groutas W.C., Chang K.O. Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses. J. Virol. 2012;86:11754\u201311762. doi: 10.1128/JVI.01348-12.", "ArticleIdList": ["10.1128/JVI.01348-12", "PMC3486288", "22915796"]}, {"Citation": "Vuong W., Khan M.B., Fischer C., Arutyunova E., Lamer T., Shields J., Saffran H.A., McKay R.T., van Belkum M.J., Joyce M.A., et al. Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication. Nat. Commun. 2020;11:4282. doi: 10.1038/s41467-020-18096-2.", "ArticleIdList": ["10.1038/s41467-020-18096-2", "PMC7453019", "32855413"]}, {"Citation": "Perera K.D., Galasiti Kankanamalage A.C., Rathnayake A.D., Honeyfield A., Groutas W., Chang K.O., Kim Y. Protease inhibitors broadly effective against feline, ferret and mink coronaviruses. Antivir. Res. 2018;160:79\u201386. doi: 10.1016/j.antiviral.2018.10.015.", "ArticleIdList": ["10.1016/j.antiviral.2018.10.015", "PMC6240502", "30342822"]}, {"Citation": "Shi Y., Shuai L., Wen Z., Wang C., Yan Y., Jiao Z., Guo F., Fu Z.F., Chen H., Bu Z., et al. The preclinical inhibitor GS441524 in combination with GC376 efficaciously inhibited the proliferation of SARS-CoV-2 in the mouse respiratory tract. Emerg. Microbes Infect. 2021;10:481\u2013492. doi: 10.1080/22221751.2021.1899770.", "ArticleIdList": ["10.1080/22221751.2021.1899770", "PMC7993387", "33691601"]}, {"Citation": "Tang B., He F., Liu D., Fang M., Wu Z., Xu D. AI-aided design of novel targeted covalent inhibitors against SARS-CoV-2. Biomolecules. 2022;12:746. doi: 10.3390/biom12060746.", "ArticleIdList": ["10.3390/biom12060746", "PMC9220321", "35740872"]}, {"Citation": "Owis A.I., El-Hawary M.S., El Amir D., Aly O.M., Abdelmohsen U.R., Kamel M.S. Molecular docking reveals the potential of Salvadora persica flavonoids to inhibit COVID-19 virus main protease. RSC Adv. 2020;10:19570\u201319575. doi: 10.1039/D0RA03582C.", "ArticleIdList": ["10.1039/D0RA03582C", "PMC9054211", "35515460"]}, {"Citation": "Kontoyianni M., McClellan L.M., Sokol G.S. Evaluation of Docking Performance:\u2009 Comparative Data on Docking Algorithms. J. Med. Chem. 2004;47:558\u2013565. doi: 10.1021/jm0302997.", "ArticleIdList": ["10.1021/jm0302997", "14736237"]}, {"Citation": "Jin Z., Du X., Xu Y., Deng Y., Liu M., Zhao Y., Zhang B., Li X., Zhang L., Peng C., et al. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020;582:289\u2013293. doi: 10.1038/s41586-020-2223-y.", "ArticleIdList": ["10.1038/s41586-020-2223-y", "32272481"]}, {"Citation": "El-Demerdash A., Al-Karmalawy A.A., Abdel-Aziz T.M., Elhady S.S., Darwish K.M., Hassan A.H.E. Investigating the structure-activity relationship of marine natural polyketides as promising SARS-CoV-2 main protease inhibitors. RSC Adv. 2021;11:31339\u201331363. doi: 10.1039/D1RA05817G.", "ArticleIdList": ["10.1039/D1RA05817G", "PMC9041294", "35496831"]}, {"Citation": "Al-Karmalawy A.A., Farid M.M., Mostafa A., Ragheb A.Y., Mahmoud S.H., Shehata M., Shama N.M.A., GabAllah M., Mostafa-Hedeab G., Marzouk M.M. Naturally Available Flavonoid Aglycones as Potential Antiviral Drug Candidates against SARS-CoV-2. Molecules. 2021;26:6559. doi: 10.3390/molecules26216559.", "ArticleIdList": ["10.3390/molecules26216559", "PMC8587465", "34770969"]}, {"Citation": "Chen Y.W., Yiu C.B., Wong K.Y. Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CLpro) structure. F1000Research. 2020;9:129. doi: 10.12688/f1000research.22457.2.", "ArticleIdList": ["10.12688/f1000research.22457.2", "PMC7062204", "32194944"]}, {"Citation": "Elhady S.S., Abdelhameed R.F.A., Malatani R.T., Alahdal A.M., Bogari H.A., Almalki A.J., Mohammad K.A., Ahmed S.A., Khedr A.I.M., Darwish K.M. Molecular Docking and Dynamics Simulation Study of Hyrtios erectus Isolated Scalarane Sesterterpenes as Potential SARS-CoV-2 Dual Target Inhibitors. Biology. 2021;10:389. doi: 10.3390/biology10050389.", "ArticleIdList": ["10.3390/biology10050389", "PMC8147222", "34062724"]}, {"Citation": "Guterres H., Im W. Improving Protein-Ligand Docking Results with High-Throughput Molecular Dynamics Simulations. J. Chem. Inf. Modeling. 2020;60:2189\u20132198. doi: 10.1021/acs.jcim.0c00057.", "ArticleIdList": ["10.1021/acs.jcim.0c00057", "PMC7534544", "32227880"]}, {"Citation": "Arnittali M., Rissanou A.N., Harmandaris V. Structure of Biomolecules through Molecular Dynamics Simulations. Procedia Comput. Sci. 2019;156:69\u201378. doi: 10.1016/j.procs.2019.08.181.", "ArticleIdList": ["10.1016/j.procs.2019.08.181"]}, {"Citation": "Liu K., Watanabe E., Kokubo H. Exploring the stability of ligand binding modes to proteins by molecular dynamics simulations. J. Comput. Aided Mol. Des. 2017;31:201\u2013211. doi: 10.1007/s10822-016-0005-2.", "ArticleIdList": ["10.1007/s10822-016-0005-2", "28074360"]}, {"Citation": "Soltan M.A., Eldeen M.A., Elbassiouny N., Kamel H.L., Abdelraheem K.M., El-Gayyed H.A., Gouda A.M., Sheha M.F., Fayad E., Ali O.A.A., et al. In Silico Designing of a Multitope Vaccine against Rhizopus microsporus with Potential Activity against Other Mucormycosis Causing Fungi. Cells. 2021;10:3014. doi: 10.3390/cells10113014.", "ArticleIdList": ["10.3390/cells10113014", "PMC8616407", "34831237"]}, {"Citation": "Hamed M.I.A., Darwish K.M., Soltane R., Chrouda A., Mostafa A., Abo Shama N.M., Elhady S.S., Abulkhair H.S., Khodir A.E., Elmaaty A.A., et al. \u03b2-Blockers bearing hydroxyethylamine and hydroxyethylene as potential SARS-CoV-2 Mpro inhibitors: Rational based design, in silico, in vitro, and SAR studies for lead optimization. RSC Adv. 2021;11:35536\u201335558. doi: 10.1039/D1RA04820A.", "ArticleIdList": ["10.1039/D1RA04820A", "PMC9043270", "35493159"]}, {"Citation": "Alnajjar R., Mostafa A., Kandeil A., Al-Karmalawy A.A. Molecular docking, molecular dynamics, and in vitro studies reveal the potential of angiotensin II receptor blockers to inhibit the COVID-19 main protease. Heliyon. 2020;6:e05641. doi: 10.1016/j.heliyon.2020.e05641.", "ArticleIdList": ["10.1016/j.heliyon.2020.e05641", "PMC7713577", "33294721"]}, {"Citation": "Abo Elmaaty A., Hamed M.I.A., Ismail M.I., Elkaeed E.B., Abulkhair H.S., Khattab M., Al-Karmalawy A.A. Computational Insights on the Potential of Some NSAIDs for Treating COVID-19: Priority Set and Lead Optimization. Molecules. 2021;26:3772. doi: 10.3390/molecules26123772.", "ArticleIdList": ["10.3390/molecules26123772", "PMC8234583", "34205704"]}, {"Citation": "Elmaaty A.A., Alnajjar R., Hamed M.I.A., Khattab M., Khalifa M.M., Al-Karmalawy A.A. Revisiting activity of some glucocorticoids as a potential inhibitor of SARS-CoV-2 main protease: Theoretical study. RSC Adv. 2021;11:10027\u201310042. doi: 10.1039/D0RA10674G.", "ArticleIdList": ["10.1039/D0RA10674G", "PMC8695394", "35423530"]}, {"Citation": "Cavasotto C.N. Binding Free Energy Calculation Using Quantum Mechanics Aimed for Drug Lead Optimization. Methods Mol. Biol. 2020;2114:257\u2013268. doi: 10.1007/978-1-0716-0282-9_16.", "ArticleIdList": ["10.1007/978-1-0716-0282-9_16", "32016898"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "6", "Day": "22"}, {"Year": "2022", "Month": "7", "Day": "21"}, {"Year": "2022", "Month": "7", "Day": "22"}, {"Year": "2022", "Month": "7", "Day": "27", "Hour": "5", "Minute": "2"}, {"Year": "2022", "Month": "7", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "28", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "7", "Day": "24"}], "PublicationStatus": "epublish", "ArticleIdList": ["35893619", "PMC9332707", "10.3390/plants11151914", "plants11151914"]}}], "PubmedBookArticle": []}